Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with stomach cancer (gastric adenocarcinoma) or cancer where the stomach meets the food pipe (gastroesophageal junction adenocarcinoma)
- You are planning to receive a medication called Sintilimab as part of your treatment
- You are generally able to carry out some daily activities (on a standard scale rating 0–2, where 0 means fully active and 2 means able to care for yourself but unable to do physical work) (confirm with trial site)
- Your doctor expects you to live for at least 3 more months
- You are willing and able to attend follow-up appointments and take part in the required tests and treatments
- You are willing to sign a consent form agreeing to take part in the study
Who may not be able to join:
- Your medical records or health information are incomplete
- You have received an immune checkpoint inhibitor treatment (a type of cancer immunotherapy drug) within the last 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13913968688
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
blood concentration of Sintilimab
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.